Literature DB >> 30835081

Anti-cancer effects of chemotherapeutic agent; 17-AAG, in combined with gold nanoparticles and irradiation in human colorectal cancer cells.

Zhino Moradi1, Mahshid Mohammadian2, Hassan Saberi1, Meysam Ebrahimifar3, Zeinab Mohammadi1, Mahnaz Ebrahimpour1, Zhaleh Behrouzkia4.   

Abstract

OBJECTIVE: The present study evaluated the anti-cancer effects of irradiation (Ir) alone, Ir after heat shock protein 90 inhibitor; 17-allylamino-17-demethoxygeldanamycin (17-AAG) and gold nanoparticle (GNP) treatments in human colorectal cancer cell line (HCT-116), with the targeting of related mechanisms.
METHODS: Water-soluble tetrazolium salt-1 assay was utilized to study the cytotoxic effects of 17-AAG, GNP, Ir in single and combination cases on the cell viability of HCT-116 cells. The cells were examined with DNA fragmentation electrophoresis and evaluated for apoptosis induction. Caspase-3 expression as a critical apoptosis element in protein level was detected by western blotting.
RESULTS: Treatment with 17-AAG in a dose dependent manner for 24 h inhibited the cellular viability of HCT-116 cells. GNP at a dose of 70 μM had the lowest cytotoxic effects and was thus selected for combination treatment studies. Based on the results, GNP at a dose of 70 μM did not have a significant effect on cellular viability of HCT-116. In contrast, the evaluation of double and triple combinations, GNP with Ir (2 Gy of 6 MV X-ray radiation) and 17-AAG in double combinations induced significant cytotoxicity. Both DNA damage pattern and caspase-3 protein upregulation were present in Ir,GNP/17-AAG,GNP and Ir,17-AAG combinations compared to single treatments. Furthermore, in the three combination of GNP,Ir,17-AAG, radiosensitization effects (increased caspase-3 expression) occurred with a minimum concentration of 17-AAG.
CONCLUSION: According to the results of this study, 17-AAG as chemotherapeutic agent in combination with Ir and GNP exerts noticeable anti-cancer effects, inhibited cell viability, and increased apoptosis occurrence by upregulating caspase-3 expression. It is suggested that these combinations should be more evaluated as a promising candidate for colorectal cancer treatment. Graphical abstract Anti-cancer effects of chemotherapeutic agent; 17-AAG, in combined with gold nanoparticles and irradiation in human colorectal cancer cells.

Entities:  

Keywords:  17-AAG; Colorectal cancer; Gold nanoparticle; HCT-116 cells; Irradiation

Mesh:

Substances:

Year:  2019        PMID: 30835081      PMCID: PMC6593031          DOI: 10.1007/s40199-019-00251-w

Source DB:  PubMed          Journal:  Daru        ISSN: 1560-8115            Impact factor:   3.117


  26 in total

1.  Cooperative enhancement of radiosensitivity after combined treatment of 17-(allylamino)-17-demethoxygeldanamycin and celecoxib in human lung and colon cancer cell lines.

Authors:  Young-Mee Kim; Hongryull Pyo
Journal:  DNA Cell Biol       Date:  2011-08-10       Impact factor: 3.311

2.  Drug combination studies and their synergy quantification using the Chou-Talalay method.

Authors:  Ting-Chao Chou
Journal:  Cancer Res       Date:  2010-01-12       Impact factor: 12.701

3.  The HSP90 inhibitor 17-allylamino-17-demethoxygeldanamycin modulates radiosensitivity by downregulating serine/threonine kinase 38 via Sp1 inhibition.

Authors:  Atsushi Enomoto; Takemichi Fukasawa; Nobuhiko Takamatsu; Michihiko Ito; Akinori Morita; Yoshio Hosoi; Kiyoshi Miyagawa
Journal:  Eur J Cancer       Date:  2013-07-22       Impact factor: 9.162

Review 4.  Methods of overcoming treatment resistance in colorectal cancer.

Authors:  Sally Temraz; Deborah Mukherji; Raafat Alameddine; Ali Shamseddine
Journal:  Crit Rev Oncol Hematol       Date:  2013-09-08       Impact factor: 6.312

Review 5.  Emerging roles of caspase-3 in apoptosis.

Authors:  A G Porter; R U Jänicke
Journal:  Cell Death Differ       Date:  1999-02       Impact factor: 15.828

6.  Blocking heat shock protein-90 inhibits the invasive properties and hepatic growth of human colon cancer cells and improves the efficacy of oxaliplatin in p53-deficient colon cancer tumors in vivo.

Authors:  Christian Moser; Sven A Lang; Silvia Kainz; Andreas Gaumann; Stefan Fichtner-Feigl; Gudrun E Koehl; Hans J Schlitt; Edward K Geissler; Oliver Stoeltzing
Journal:  Mol Cancer Ther       Date:  2007-11       Impact factor: 6.261

7.  Additive interaction of oxaliplatin and 17-allylamino-17-demethoxygeldanamycin in colon cancer cell lines results from inhibition of nuclear factor kappaB signaling.

Authors:  Tatiana V Rakitina; Irina A Vasilevskaya; Peter J O'Dwyer
Journal:  Cancer Res       Date:  2003-12-15       Impact factor: 12.701

8.  DNA fragmentation and apoptosis induced by safranal in human prostate cancer cell line.

Authors:  Saeed Samarghandian; Mahmoud M Shabestari
Journal:  Indian J Urol       Date:  2013-07

9.  Synergistic effect of heat shock protein 90 inhibitor, 17-allylamino-17-demethoxygeldanamycin and X-rays, but not carbon-ion beams, on lethality in human oral squamous cell carcinoma cells.

Authors:  Atsushi Musha; Yukari Yoshida; Takeo Takahashi; Koichi Ando; Tomoo Funayama; Yasuhiko Kobayashi; Akihide Negishi; Satoshi Yokoo; Takashi Nakano
Journal:  J Radiat Res       Date:  2012-07       Impact factor: 2.724

10.  Mode of cell death induced by the HSP90 inhibitor 17-AAG (tanespimycin) is dependent on the expression of pro-apoptotic BAX.

Authors:  Marissa V Powers; Melanie Valenti; Susana Miranda; Alison Maloney; Suzanne A Eccles; George Thomas; Paul A Clarke; Paul Workman
Journal:  Oncotarget       Date:  2013-11
View more
  9 in total

Review 1.  Ins and Outs of Heat Shock Proteins in Colorectal Carcinoma: Its Role in Carcinogenesis and Therapeutic Perspectives.

Authors:  Batoul Abi Zamer; Waseem El-Huneidi; Mohamed Ahmed Eladl; Jibran Sualeh Muhammad
Journal:  Cells       Date:  2021-10-24       Impact factor: 6.600

2.  Effects of Radiotherapy in Combination With Irinotecan and 17-AAG on Bcl-2 and Caspase 3 Gene Expression in Colorectal Cancer Cells.

Authors:  Mahnaz Ebrahimpour; Mahshid Mohammadian; Bagher Pourheydar; Zhino Moradi; Zhaleh Behrouzkia
Journal:  J Lasers Med Sci       Date:  2022-02-28

3.  Regulatory Effects of Apatinib in Combination with Piperine on MDM-2 Gene Expression, Glutathione Peroxidase Activity and Nitric Oxide level as Mechanisms of Cytotoxicity in Colorectal Cancer Cells.

Authors:  Mahshid Mohammadian; Zakieh Rostamzadeh Khameneh; Soraya Emamgholizadeh Minaei; Meysam Ebrahimifar; Kosar Esgandari
Journal:  Adv Pharm Bull       Date:  2021-04-03

4.  Combination effects of capecitabine, irinotecan and 17-AAG on colorectal cancer cell line (HT-29).

Authors:  Shima Zeynali-Moghaddam; Fatemeh Kheradmand; Shiva Gholizadeh-Ghaleh Aziz; Sina Abroon
Journal:  Ann Med Surg (Lond)       Date:  2022-05-24

Review 5.  Controlled-Release Nanosystems with a Dual Function of Targeted Therapy and Radiotherapy in Colorectal Cancer.

Authors:  Pedro Cruz-Nova; Alejandra Ancira-Cortez; Guillermina Ferro-Flores; Blanca Ocampo-García; Brenda Gibbens-Bandala
Journal:  Pharmaceutics       Date:  2022-05-20       Impact factor: 6.525

6.  Dihydropyrimidine Dehydrogenase Levels in Colorectal Cancer Cells Treated with a Combination of Heat Shock Protein 90 Inhibitor and Oxaliplatin or Capecitabine.

Authors:  Mahshid Mohammadian; Shima Zeynali-Moghaddam; Mohammad Hassan Khadem Ansari; Yousef Rasmi; Anahita Fathi Azarbayjani; Fatemeh Kheradmand
Journal:  Adv Pharm Bull       Date:  2019-08-01

7.  Hsp90 Inhibitor; NVP-AUY922 in Combination with Doxorubicin Induces Apoptosis and Downregulates VEGF in MCF-7 Breast Cancer Cell Line.

Authors:  Mahshid Mohammadian; Sadegh Feizollahzadeh; Reza Mahmoudi; Attabak Toofani Milani; Soheila Rezapour-Firouzi; Bahareh Karimi Douna
Journal:  Asian Pac J Cancer Prev       Date:  2020-06-01

Review 8.  Surface-functionalised hybrid nanoparticles for targeted treatment of cancer.

Authors:  Hasnat Tariq; Syed Ali Imran Bokhari
Journal:  IET Nanobiotechnol       Date:  2020-09       Impact factor: 1.847

9.  Carboplatin and epigallocatechin-3-gallate synergistically induce cytotoxic effects in esophageal cancer cells.

Authors:  Fatemeh Taghvaei; Sepideh Jafarzadeh Rastin; Attabak Toofani Milani; Zakieh Rostamzadeh Khameneh; Forough Hamini; Mohammad Aziz Rasouli; Keivan Asghari; Amir Mohammad Rekabi Shishavan; Meysam Ebrahimifar; Siamak Rashidi
Journal:  Res Pharm Sci       Date:  2021-05-12
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.